Phathom Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
PHAT
CUSIP
71722W107
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 71722W107 since 12/18/2024, largest first.

Filer % of Class Filed
Frazier Life Sciences Public Fund, L.P. 13D/A
7.4% 11/2/2026
Event 10/29/2026
BlackRock, Inc. 13G 5.5% 7/29/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Carlyle Group Inc. 13G/A
4.9% 8/28/2025
Event 8/28/2025
Millennium Management LLC 13G/A
4.2% 7/20/2026
Event 6/30/2026
Invesco Ltd. 13G/A 0% 11/10/2026
Event 9/30/2026
Prudential Financial Inc 13G/A 0% 6/6/2025
Event 5/31/2025
Jennison Associates LLC 13G/A 0% 6/9/2025
Event 5/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 164 70.3 M $509M
2026 Q2 163 72.1 M $782M
2026 Q1 177 69.2 M $768M
2025 Q4 174 62.0 M $1.03B
2025 Q3 134 62.3 M $734M
2025 Q2 122 57.4 M $551M
2025 Q1 139 64.0 M $401M
2024 Q4 145 66.7 M $541M
2024 Q3 134 72.6 M $1.31B
2024 Q2 116 58.1 M $599M
2024 Q1 116 55.4 M $588M
2023 Q4 119 54.1 M $503M
2023 Q3 112 43.8 M $453M
2023 Q2 104 42.8 M $613M
2023 Q1 85 30.8 M $220M
2022 Q4 89 28.4 M $318M
2022 Q3 96 30.2 M $334M
2022 Q2 96 27.3 M $237M
2022 Q1 86 25.7 M $350M
2021 Q4 85 28.6 M $562M
2021 Q3 85 25.5 M $820M
2021 Q2 81 24.9 M $844M
2021 Q1 85 24.5 M $919M
2020 Q4 77 24.5 M $815M
2020 Q3 59 21.6 M $794M
2020 Q2 62 21.8 M $719M
2020 Q1 48 21.9 M $566M
2019 Q4 41 21.8 M $677M